Stakeholders will get a chance to sound off on the Food and Drug Administration (FDA)'s proposal to raise device user fees in exchange for shorter review times.
Â
The agency will hold a public workshop on March 28, 2012Â in Washington, D.C. on the reauthorization of the medical device user fee program.
The FDA reached a preliminary deal with manufacturers in February to collect $595 million in fees for device applications over the next five years. Thats roughly double what the agency has collected over the past five years, and industry officials agreed to the increase in exchange for improvements in the device review process.
For example, the FDA agreed to hire more than 200 full-time workers by the end of the five-year program, and interact with companies earlier in the submission process.
In terms of specifics, for a 510(k) application, a device maker would pay 2 percent of the fee for a premarket approval (PMA) application, up from 1.84 percent, according to draft legislative language.
 Â
The agreement with FDA enhances both the predictability and transparency of the agency, says Lindsay Morris, senior director of government relations for the Medical Imaging and Technology Alliance, an imaging technology trade association based in Arlington, Va. In a time of tremendous advances in imaging and radiation therapy technologies, the agreement enables the industry to bring innovative, life-saving technologies to market faster, so that patients receive the care they need.
After considering the comments, the FDA will send a final proposal to Congress, which must decide by Sept. 30 whether to reauthorize the program or let it expire.
Source: AAMI
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Ensuring Safe Practices: Managing Surgical Instruments in the Context of Creutzfeldt-Jakob Disease
February 27th 2025Creutzfeldt-Jakob Disease (CJD) presents significant challenges for infection control. Learn best practices for safe instrument disposal, reprocessing, and compliance with CDC and WHO guidelines.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.